Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

L Puig¹

Affiliations

Comment

L Puig. Br J Dermatol. 2021 Jun.

. 2021 Jun;184(6):992-993.

doi: 10.1111/bjd.19696. Epub 2020 Dec 21.

L Puig¹

¹ Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

No abstract available

Comment on

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.
Blauvelt A, Leonardi C, Elewski B, Crowley JJ, Guenther LC, Gooderham M, Langley RG, Vender R, Pinter A, Griffiths CEM, Tada Y, Elmaraghy H, Lima RG, Gallo G, Renda L, Burge R, Park SY, Zhu B, Papp K; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2021 Jun;184(6):1047-1058. doi: 10.1111/bjd.19509. Epub 2020 Oct 25. Br J Dermatol. 2021. PMID: 32880909 Free PMC article. Clinical Trial.

1. Blauvelt A, Leonardi C, Elewski B et al.; IXORA-R Study Group. A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. Br J Dermatol 2020. https://doi.org/10.1111/bjd.19509.
1. Blauvelt A, Papp K, Gottlieb A et al. IXORA-R Study Group. A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. Br J Dermatol 2020; 182:1348-58.
1. Gottlieb AB, Saure D, Wilhelm S et al. Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12. J Dermatol Treat 2020; https://doi.org/10.1080/09546634.2020.1747592.
1. Warren RB, See K, Burge R et al. Rapid response of biologic treatments of moderate-to-severe plaque psoriasis: a comprehensive investigation using Bayesian and Frequentist network meta-analyses. Dermatol Ther 2020; 10:73-86.
1. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol JEADV 2009; 23 (Suppl. 1):9-13.